このエントリーをはてなブックマークに追加
ID 52703
タイトル(別表記)
Induction therapy followed by surgery for non small-cell lung cancer
フルテキストURL
Thumnail 126_103.pdf 473 KB
著者
豊岡 伸一 岡山大学大学院医歯薬学総合研究科 臨床遺伝子医療学
キーワード
非小細胞肺癌
導入療法
放射線化学療法
外科切除
備考
総説 (Reviews)
出版物タイトル
岡山医学会雑誌
発行日
2014-08-01
126巻
2号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
103
終了ページ
107
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
OAI-PMH Set
岡山大学
言語
Japanese
著作権者
Copyright (c) 2014 岡山医学会
論文のバージョン
publisher
査読
有り
DOI
NAID
Sort Key
7
Eprints Journal Name
joma
参考文献
1) Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, et al. : A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst (1994) 86, 673-680.
2) Rosell R, Gómez-Codina J, Camps C, Maestre J, Padille J, Cantó A, Mate JL, Li S, Roig J, Olazábal A, et al. : A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med (1994) 330, 153-158.
3) Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, et al. : Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages ⅢA (N2) and ⅢB non-small-cell lung cancer : mature results of Southwest Oncology Group phaseⅡstudy 8805. J Clin Oncol (1995) 13, 1880-1892.
4) Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, et al. : Radiotherapy plus chemotherapy with or without surgical resection for stageⅢnon-small-cell lung cancer : a phase Ⅲrandomised controlled trial. Lancet (2009) 374, 379-386.
5) van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G ; European Organisation for Research and Treatment of Cancer-Lung Cancer Group : Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage ⅢA-N2 non-small-cell lung cancer. J Natl Cancer Inst (2007) 99, 442-450.
6) Date H, Kiura K, Ueoka H, Tabata M, Aoe M, Andou A, Shibayama T, Shimizu N : Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N(2) non-small cell lung cancer. Br J Cancer (2002) 86, 530-533.
7) Katayama H, Ueoka H, Kiura K, Tabata M, Kozuki T, Tanimoto M, Fujiwara T, Tanaka N, Date H, Aoe M, Shimizu N, Takemoto M, et al. : Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer (2004) 90, 979-984.
8) Toyooka S, Kiura K, Takemoto M, Oto T, Takigawa N, Fujiwara T, Miyoshi S, Date H : Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg (2012) 14, 565-569.
9) Toyooka S, Kiura K, Shien K, Katsui K, Hotta K, Kanazawa S, Date H, Miyoshi S : Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg (2012) 15, 954-960.
10) Shien K, Toyooka S, Kiura K, Matsuo K, Soh J, Yamane M, Oto T, Takemoto M, Date H, Miyoshi S : Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer. Ann Surg Oncol (2012) 19, 2685-2692.
11) Felip E, Rosell R, Maestre JA, Rodríguez-Paniagua JM, Morán T, Astudillo J, Alonso G, Borro JM, González-Larriba JL, Torres A, Camps C, Guijarro R,et al. ; Spanish Lung Cancer Group : Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol (2010) 28, 3138-3145.
12) NSCLC Meta-analysis Collaborative Group : Preoperative chemotherapy for non-small cell lung cancer : a systematic review and meta-analysis of individual participant data. Lancet (2014) 383, 1561-1571.
13) Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara D : Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas : long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol (2007) 25, 313-318.
14) Kunitoh H, Kato H, Tsuboi M, Shibata T, Asamura H, Ichinose Y, Katakami N, Nagai K, Mitsudomi T, Matsumura A, Nakagawa K, Tada H, et al. ; Japan Clinical Oncology Group : PhaseⅡtrial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers : report of Japan Clinical Oncology Group trial 9806. J Clin Oncol (2008) 26, 644-649.
15) Toyooka S, Soh J, Oto T, Miyoshi S : Bronchoplasty to adjust mismatches in the proximal and distal bronchial stumps during bronchial sleeve resection of the left lower lobe and lingular division. Eur J Cardiothorac Surg (2013) 43, 182-183.
16) Toyooka S, Soh J, Shien K, Sugimoto S, Yamane M, Oto T, Date H, Miyoshi S : Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy. Eur J Cardiothorac Surg (2013) 43, 568-572.
17) Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, et al. : Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 350, 2129-2139.
18) Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, et al. : EGFR mutations in lung cancer : correlation with clinical response to gefitinib therapy. Science (2004) 304, 1497-1500.
19) Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, et al. : Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature (2007) 448, 561-566.
20) Cappuzzo F, Bemis L, Varella-Garcia M : HER2 mutation and response to trastuzumab therapy in non-small-cell lung cancer. N Engl J Med (2006) 354, 2619-2621.
21) Gautschi O, Pauli C, Strobel K, Hirschmann A, Printzen G, Aebi S, Diebold J : A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib. J Thorac Oncol (2012) 7, e23-24.
22) Shigematsu H, Gazdar AF : Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer (2006) 118, 257-262.
23) Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, et al. : KIF5B-RET fusions in lung adenocarcinoma. Nat Med (2012) 18, 375-377.
24) Hishida T, Nagai K, Mitsudomi T, Yokoi K, Kondo H, Horinouchi H, Akiyama H, Nagayasu T, Tsuboi M ; Japan Clinical Oncology G : Salvage surgery for advanced non-small cell lung cancer after response to gefitinib. J Thorac Cardiovasc Surg (2010) 140, e69-71.
25) Jaklitsch MT, Herndon JE 2nd, DeCamp MM Jr, Richards WG, Kumar P, Krasna MJ, Green MR, Sugarbaker DJ : Nodal downstaging predicts survival following induction chemotherapy for stage ⅢA (N2) non-small cell lung cancer in CALGB protocol #8935. J Surg Oncol (2006) 94, 599-606.
26) Shintani Y, Okimura A, Sato K, Nakagiri T, Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, Matsumoto T, Matsuura N, et al. : Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg (2011) 92, 1794-1804 ; discussion 1804.
27) Shien K, Toyooka S, Ichimura K, Soh J, Furukawa M, Maki Y, Muraoka T, Tanaka N, Ueno T, Asano H, Tsukuda K, Yamane M, et al. : Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Lung Cancer (2012) 77, 162-167.